When ValueWalk first reported that Allergan PLC was planning on engaging in a more aggressive roll-up strategy, citing unnamed sources in corporate meetings and confirmed by someone with visibility into the execution strategy, the speculation quickly spread as to what company was on the acquisition menu. The facts behind the exclusive reporting was later confirmed, but what many inside the financial services industry who plot the future probability paths with a mathematical precision didn’t consider was Allergan in talks to merge with the giant drug maker Pfize Inc, as first reported in the Wall Street Journal. Pfizer – Allergan relationship…
Pfizer – Allergan Hook Up Could Run Into "Currency" Issues
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.